There were 579 press releases posted in the last 24 hours and 399,958 in the last 365 days.

Global Vaccine Adjuvants Market Analysis, Trends, and Forecasts 2019-2025

Dublin, Nov. 18, 2019 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Vaccine Adjuvants market worldwide is projected to grow by US$492.1 Million, driven by a compounded growth of 10.2%.

Particulate Adjuvants, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$337.2 Million by the year 2025, Particulate Adjuvants will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$22 Million to the region's size and clout in the next 5 to 6 years. Over US$49.5 Million worth of projected demand in the region will come from other emerging Eastern European markets.

In Japan, Particulate Adjuvants will reach a market size of US$30.1 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.7% over the next couple of years and add approximately US$83.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include the following, among others:

  • Agenus, Inc. (USA)
  • Avanti Polar Lipids, Inc. (USA)
  • Brenntag Biosector A/S (Denmark)
  • CSL Ltd. (Australia)
  • Invivogen (USA)
  • Mvp Laboratories Inc. (USA)
  • Novavax, Inc. (USA)
  • OZ Biosciences SAS (France)
  • Seppic SA (France)
  • SPI Pharma (USA)

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Vaccine Adjuvants Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Global Competitor Market Shares by Segment
  • Particulate Adjuvants (Type) Global Competitor Market Share Positioning for 2019 & 2025
  • Adjuvant Emulsions (Type) Market Share Breakdown of Key Players: 2019 & 2025
  • Pathogen Components (Type) Competitor Revenue Share (in %): 2019 & 2025
  • Combination Adjuvants (Type) Market Share Shift by Company: 2019 & 2025
  • Subcutaneous (Route Of Administration) Global Competitor Market Share Positioning for 2019 & 2025
  • Intramuscular (Route Of Administration) Market Share Breakdown of Key Players: 2019 & 2025
  • Intranasal Route (Route Of Administration) Competitor Revenue Share (in %): 2019 & 2025
  • Oral Route (Route Of Administration) Market Share Shift by Company: 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

  • Market Facts & Figures
  • US Vaccine Adjuvants Market Share (in %) by Company: 2019 & 2025
  • Particulate Adjuvants (Type) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025
  • Adjuvant Emulsions (Type) Competitor Revenue Share (in %) in the US: 2019 & 2025
  • Pathogen Components (Type) Market Share Breakdown (in %) of Major Players in the US: 2019 & 2025
  • Combination Adjuvants (Type) Market in the US: Percentage Breakdown of Revenues by Company for 2019 & 2025
  • Subcutaneous (Route Of Administration) Competitor Market Share Breakdown (in %) in the US for 2019 & 2025
  • Intramuscular (Route Of Administration) Market: Revenue Share Breakdown (in %) of Key Players in the US: 2019 & 2025
  • Intranasal Route (Route Of Administration) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025
  • Oral Route (Route Of Administration) Competitor Revenue Share (in %) in the US: 2019 & 2025

CANADA

JAPAN

CHINA

EUROPE

  • Market Facts & Figures
  • European Vaccine Adjuvants Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Particulate Adjuvants (Type) Market Share (in %) by Company in Europe: 2019 & 2025
  • Adjuvant Emulsions (Type) Market Share (in %) of Major Players in Europe: 2019 & 2025
  • Pathogen Components (Type) Competitor Market Share Analysis (in %) in Europe: 2019 & 2025
  • Combination Adjuvants (Type) Market in Europe: Competitor Revenue Share Shift (in %) for 2019 & 2025
  • Subcutaneous (Route Of Administration) Competitor Market Share (in %) Positioning in Europe for 2019 & 2025
  • Intramuscular (Route Of Administration) Key Player Market Share Breakdown (in %) in Europe: 2019 & 2025
  • Intranasal Route (Route Of Administration) Market Share (in %) by Company in Europe: 2019 & 2025
  • Oral Route (Route Of Administration) Market Share (in %) of Major Players in Europe: 2019 & 2025

FRANCE

GERMANY

ITALY

UNITED KINGDOM

REST OF EUROPE

ASIA-PACIFIC

REST OF WORLD

IV. COMPETITION

V. CURATED RESEARCH

For more information about this report visit https://www.researchandmarkets.com/r/au49or

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo